1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Results 61-80 of 184 (Search time: 0.017 seconds).

Issue DateTitleAuthor(s)
611-Sep-2016Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association studyLi, Zheng; Xia, Yi; Feng, Li-Na; Chen, Jie-Rong; Li, Hong-Min; Cui, Jing; Cai, Qing-Qing; Sim, Kar Seng; Nairismagi, Maarja-Liisa; Laurensia, Yurike; Meah, Wee Yang; Liu, Wen-Sheng; Guo, Yun-Miao; Chen, Li-Zhen; Feng, Qi-Sheng; Pang, Chi Pui; Chen, Li Jia; Chew, Soo Hong ; Ebstein, Richard P; Foo, Jia Nee; Liu, Jianjun; Ha, Jeslin; Khoo, Lay Poh; Chin, Suk Teng; Zeng, Yi-Xin; Aung, Tin; Chowbay, Balram ; Diong, Colin Phipps; Zhang, Fen; Liu, Yan-Hui; Tang, Tiffany; Tao, Miriam; Quek, Richard; Mohamad, Farid; Tan, Soo Yong ; Teh, Bin Tean ; Ng, Siok Bian ; Chng, Wee Joo ; Ong, Choon Kiat ; Okada, Yukinori; Raychaudhuri, Soumya; Lim, Soon Thye; Tan, Wen; Peng, Rou-Jun; Khor, Chiea Chuen; Bei, Jin-Xin
622015Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myelomaBi, C; Chung, T.-H ; Huang, G ; Zhou, J ; Yan, J ; Ahmann, G.J; Fonseca, R; Chng, W.J 
6331-Jan-2022Genomic characterization of functional high-risk multiple myeloma patientsSoekojo, Cinnie Yentia; Chung, Tae-Hoon ; Furqan, Muhammad Shaheryar; Chng, Wee Joo 
64Nov-2013Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study GroupKim, S.J.; Hsu, C.; Song, Y.-Q.; Tay, K.; Hong, X.-N.; Cao, J.; Kim, J.S.; Eom, H.S.; Lee, J.H.; Zhu, J.; Chang, K.-M.; Reksodiputro, A.H.; Tan, D.; Goh, Y.T.; Lee, J.; Intragumtornchai, T.; Chng, W.-J. ; Cheng, A.-L.; Lim, S.T.; Suh, C.; Kwong, Y.-L.; Kim, W.S.
6512-Aug-2021High-dose methotrexate is effective for prevention of isolated CNS relapse in diffuse large B cell lymphomaOng, Shin Yeu ; de Mel, Sanjay; Grigoropoulos, Nicholas Francis ; Chen, Yunxin ; Tan, Yan Chin; Tan, Melinda Si Yun ; Ng, Lawrence Cheng Kiat ; Lee, Yuh Shan; Phipps, Colin; Goh, Yeow Tee ; Yong, Kar Ying; Liu, Xin; Chng, Wee Joo ; Lim, Soon Thye ; Nagarajan, Chandramouli 
662015High-throughput mutation profiling changes before and 3 weeks after chemotherapy in newly diagnosed breast cancer patientsTan S.-H.; Sabrina Sapari N.; Miao H.; Hartman M. ; Loh M.; Chng W.-J. ; Iau P.; Ahmad Buhari S.; Soong R. ; Lee S.-C.
6719-Jul-2021Identification of differential RNA modifications from nanopore direct RNA sequencing with xPorePratanwanich, Ploy N; Yao, Fei; Chen, Ying; Koh, Casslynn WQ; Wan, Yuk Kei; Hendra, Christopher; Poon, Polly; Goh, Yeek Teck; Yap, Phoebe ML; Chooi, Jing Yuan; Chng, Wee Joo ; Ng, Sarah B; Thiery, Alexandre ; Goh, WS Sho; Goke, Jonathan
6815-Sep-2019IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple MyelomaChong, Phyllis SY ; Zhou, Jianbiao ; Lim, Julia SL ; Hee, Yan Ting; Chooi, Jing-Yuan ; Chung, Tae-Hoon ; Tan, Zea Tuan ; Zeng, Qi ; Waller, Daniel D; Sebag, Michael; Chng, Wee-Joo 
691-May-2020IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplificationTeoh, Phaik Ju ; Chung, Tae-Hoon; Chng, Pamela YZ; Toh, Sabrina HM ; Chng, Wee Joo 
7013-Jan-2022Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS.Wai, Cho Mar Myint; Chen, Shangying ; Phyu, The ; Fan, Shuangyi ; Leong, Sai Mun ; Zheng, Wenning ; Low, Louis Ching Yi; Choo, Shoa-Nian ; Lee, Chi-Kuen ; Chung, Tae-Hoon ; Ban, Kenneth Hon Kim; Ghosh, Soumita; Lie, Stefanus; Kato, Seiichi; Nakamura, Shigeo; Takahashi, Emiko; Ko, Young-Hyeh; Khoury, Joseph D; Chuang, Shih-Sung; Au-Yeung, Rex KH; Tan, Soo-Yong ; Lim, Soon-Thye ; Ong, Choon-Kiat ; Ho, Yong-Howe; Poon, Li Mei; De Mel, Sanjay; Jeyasekharan, Anand D ; Chng, Wee-Joo ; Otto, Franziska; Quintanilla-Martinez, Leticia; Zanardi, Federica; Iannelli, Fabio; Tripodo, Claudio; Pitt, Jason J; Ng, Siok-Bian 
719-Jun-2022Immunoglobulin M Monoclonal Gammopathies of Clinical SignificanceGirard, Louis-Pierre; Soekojo, Cinnie Yentia; Ooi, Melissa; Chng, Wee Joo ; de Mel, Sanjay
722020Immunoglobulin m paraproteinaemiasGirard, L.-P.; Soekojo, C.Y.; Ooi, M.; Poon, L.M.; Chng, W.-J. ; de Mel, S.
731-Mar-2020Immunotherapy in Multiple MyelomaSoekojo, Cinnie Yentia; Ooi, Melissa ; de Mel, Sanjay; Chng, Wee Joo 
74Nov-2022Impact of ixazomib-lenalidomide-dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging-markets subgroup of the TOURMALINE-MM1 trial.Spencer, Andrew; Samoilova, Olga; Chng, Wee-Joo ; Labotka, Richard; Li, Cong; Wu, Kwang-Wei; Saxena, Nakul; Yan, Xu; Lee, Jae Hoon; Beksac, Meral
751-Jan-2017Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR studyMoreau, P; Joshua, D; Chng, W-J ; Palumbo, A; Goldschmidt, H; Hajek, R; Facon, T; Ludwig, H; Pour, L; Niesvizky, R; Oriol, A; Rosinol, L; Suvorov, A; Gaidano, G; Pika, T; Weisel, K; Goranova-Marinova, V; Gillenwater, HH; Mohamed, N; Aggarwal, S; Feng, S; Dimopoulos, MA
762014Implications of heterogeneity in multiple myelomaDe Mel S.; Lim S.H.; Tung M.L.; Chng W.-J. 
77Feb-2014IMWG consensus on risk stratification in multiple myelomaChng, W.J. ; Dispenzieri, A.; Chim, C.-S.; Fonseca, R.; Goldschmidt, H.; Lentzsch, S.; Munshi, N.; Palumbo, A.; Miguel, J.S.; Sonneveld, P.; Cavo, M.; Usmani, S.; Durie, B.G.; Avet-Loiseau, H.
782010Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigenesis in a human B-cell modelYustein, J.T.; Liu, Y.-C.; Vuica-Ross, M.; Eberhart, C.G.; Dang, C.V.; Gao, P.; Le, A.; Jie, C.; Chng, W.J. ; Bergsagel, P.L.
792017Inhibition of LIN28B impairs leukemia cell growth and metabolism in acute myeloid leukemiaZhou, J ; Bi, C; Ching, Y.Q ; Chooi, J.-Y ; Lu, X; Quah, J.Y ; Toh, S.H.-M ; Chan, Z.-L; Tan, T.Z ; Chong, P.S ; Chng, W.-J 
801-Dec-2020Ixazomib as Postinduction Maintenance for Patients With Newly Diagnosed Multiple Myeloma Not Undergoing Autologous Stem Cell Transplantation: The Phase III TOURMALINE-MM4 TrialDimopoulos, Meletios A; Spicka, Ivan; Quach, Hang; Oriol, Albert; Hajek, Roman; Garg, Mamta; Beksac, Meral; Bringhen, Sara; Katodritou, Eirini; Chng, Wee-Joo ; Leleu, Xavier; Iida, Shinsuke; Mateos, Maria-Victoria; Morgan, Gareth; Vorog, Alexander; Labotka, Richard; Wang, Bingxia; Palumbo, Antonio; Lonial, Sagar